Rise in adoption of Assisted Reproductive Technology (ART) is augmenting the in vitro fertilization market size. ARTs have spread worldwide leading to the conception and birth of over eight million babies since being implemented in 1978.
Technological advancements in ART are also boosting the in vitro fertilization market development share. These advances include improvements in ovulation induction protocols, the introduction of recombinant gonadotropins, GnRH agonists, and GnRH antagonists.
Key players are focusing on advancements in cryopreservation techniques for in vitro fertilization. Freeze-all strategy has emerged as an accepted and valuable alternative to fresh embryo transfer in ART.
In Vitro Fertilization (IVF) is an Assisted Reproductive Technology (ART) that helps a woman become pregnant. In this process, a woman's ovaries are carefully stimulated to create numerous eggs, which are subsequently collected and mixed with sperm in a lab environment.
One or more healthy embryos are chosen for transfer into the woman's uterus after the developing embryos are carefully observed for quality and development. IVF can be customized to treat a variety of infertility factors, including low sperm counts, fallopian tube obstructions, and inexplicable fertility problems.
The global in vitro fertilization market is expected to grow at a steady pace during the forecast period due to several factors such as rise in the median age of first-time mothers and growth in male infertility.
Surge in cases of obesity, alcohol consumption, and public awareness regarding infertility and treatment alternatives is also boosting the demand for IVF.
| Attribute | Detail |
|---|---|
| Drivers |
|
IVF is a process that involves extracting a woman's eggs, fertilizing them in a lab, and then transferring the resulting embryo into the uterus through the cephalic vein which is carried out in fertility clinics in the form of Assisted Reproductive Technology (ART).
Fertility clinics offer specific medical care to individuals and couples who are having difficulty conceiving. These clinics help people reach their intended family planning objectives by providing a variety of treatments such as IVF, egg freezing, artificial conception, and fertility preservation. Hence, increase in adoption of ART is fueling the in vitro fertilization market demand.
According to the Centers for Disease Control and Prevention (CDC)’s 2021 Fertility Clinic Success Rates Report, approximately 238,126 patients had 413,776 ART cycles performed at 453 reporting clinics in the U.S. in 2021, resulting in 91,906 live births (deliveries of one or more living infants) and 97,128 live-born infants.
Of the 413,776 ART cycles performed in 2021, 167,689 were egg or embryo banking cycles in which all resulting eggs or embryos were frozen for future use.
Sperm separation systems are employed in the majority of ARTs such as artificial insemination and IVF since these systems provide refined samples for further processing.
Vendors in the in vitro fertilization market landscape are developing innovative equipment that can be employed in ART operations carried out by fertility clinics and obstetrician-gynecologist (OB/GYN) practices.
In March 2022, Malta took a significant step in the field of reproductive health by collaborating with Pera Labs, a groundbreaking fertility tech company.
The company announced the start of research and development of an AI-powered sperm and egg selection technology for fertility treatments to assist clinics in reducing their standard 70% treatment failure rate.
Growth in utilization of advanced technologies, such as sperm syringes, in selecting quality sperm is expected to create significant in vitro fertilization market opportunities for vendors since these syringes provide clinics with a better way to employ less invasive ARTs and reduce the associated clinical burden and enhance long-term health outcomes for ART-conceived infants.
| Attribute | Detail |
|---|---|
| Leading Region | Asia Pacific |
According to the latest in vitro fertilization market analysis, Asia Pacific held largest share in 2023. Large population base, declining fertility rates, and increase in number of government-funded initiatives intended for women are propelling the market dynamics of the region.
Surge in awareness regarding infertility is also fueling the in vitro fertilization market share in Asia Pacific. Growth in incidence of infertility can be ascribed to increase in levels of smoking, alcohol consumption, use of some illicit drugs, and underlying problems, including obesity.
Surge in rates of late marriages and pregnancy age is bolstering the in vitro fertilization industry growth in Asia Pacific. According to the study,’ Desire to Delay the First Childbirth Among Young, Married Women in India: A Cross-Sectional Study Based on National Survey Data’, published in 2020, among never pregnant, married women aged 15-24, 21.49% reported a preferred waiting time for their first childbirth of 2 years or more.
Expansion in medical tourism sector is also expected to influence the in vitro fertilization market trends. India is one of the famous destinations for global medical tourism. India provides affordable medical outsourcing facilities to foreign patients seeking a cure for their infertility.
Thus, major international vendors are investing in Indian companies. In 2021, Nova IVF (backed by TPG), acquired a 51% stake in Southend Fertility, a Delhi-based IVF chain.
Key players operating in the in vitro fertilization industry are developing innovative digital platforms to enhance clinical and scientific decisions with insights gained via artificial intelligence and machine learning to provide targeted treatment regimens.
Vitrolife AB, Cook Medical, Thermo Fisher Scientific, Inc., Merck KGAA, Ovascience, Inc., CooperSurgical, Genea Ltd., Rocket Medical PLC, and Fertility Focus Ltd. are some of the key players operating in this market.
These companies have been profiled in the in vitro fertilization market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 781.1 Mn |
| Market Forecast (Value) in 2034 | US$ 1.5 Bn |
| Growth Rate (CAGR) | 6.2% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn/Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 781.1 Mn in 2023
It is projected to grow at a CAGR of 6.2% from 2024 to 2034
Rise in adoption of assisted reproductive technology and technological advancements in ART
Asia Pacific was the leading region in 2023
Vitrolife AB, Cook Medical, Thermo Fisher Scientific, Inc., Merck KGAA, Ovascience, Inc., CooperSurgical, Genea Ltd., Rocket Medical PLC, and Fertility Focus Ltd.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global In Vitro Fertilization Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global In Vitro Fertilization Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global In Vitro Fertilization Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2020-2034
6.3.1. Equipment
6.3.2. Reagents & Media
6.3.3. Accessories
6.4. Market Attractiveness, by Product
7. Global In Vitro Fertilization Market Analysis and Forecast, by Cycle
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Cycle, 2020-2034
7.3.1. Fresh Non-donor Cycle
7.3.2. Frozen Non-donor IVF Cycle
7.3.3. Frozen donor IVF Cycle
7.3.4. Fresh donor IVF Cycle
7.4. Market Attractiveness, by Cycle
8. Global In Vitro Fertilization Market Analysis and Forecast, by Type
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Type, 2020-2034
8.3.1. Conventional IVF
8.3.2. IVF with ICSI
8.3.3. IVF with Donor Eggs
8.4. Market Attractiveness, by Type
9. Global In Vitro Fertilization Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Fertility Clinics
9.3.2. Hospitals & Surgical Centers
9.3.3. Cryobanks & Research Institutes
9.4. Market Attractiveness, by End-user
10. Global In Vitro Fertilization Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America In Vitro Fertilization Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2020-2034
11.2.1. Equipment
11.2.2. Reagents & Media
11.2.3. Accessories
11.3. Market Attractiveness, by Product
11.4. Market Value Forecast, by Cycle, 2020-2034
11.4.1. Fresh Non-donor Cycle
11.4.2. Frozen Non-donor IVF Cycle
11.4.3. Frozen donor IVF Cycle
11.4.4. Fresh donor IVF Cycle
11.5. Market Attractiveness, by Cycle
11.6. Market Value Forecast, by Type, 2020-2034
11.6.1. Conventional IVF
11.6.2. IVF with ICSI
11.6.3. IVF with Donor Eggs
11.7. Market Attractiveness, by Type
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Fertility Clinics
11.8.2. Hospitals & Surgical Centers
11.8.3. Cryobanks & Research Institutes
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product
11.11.2. By Cycle
11.11.3. By Type
11.11.4. By End-user
11.11.5. By Country
12. Europe In Vitro Fertilization Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2020-2034
12.2.1. Equipment
12.2.2. Reagents & Media
12.2.3. Accessories
12.3. Market Attractiveness, by Product
12.4. Market Value Forecast, by Cycle, 2020-2034
12.4.1. Fresh Non-donor Cycle
12.4.2. Frozen Non-donor IVF Cycle
12.4.3. Frozen donor IVF Cycle
12.4.4. Fresh donor IVF Cycle
12.5. Market Attractiveness, by Cycle
12.6. Market Value Forecast, by Type, 2020-2034
12.6.1. Conventional IVF
12.6.2. IVF with ICSI
12.6.3. IVF with Donor Eggs
12.7. Market Attractiveness, by Type
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Fertility Clinics
12.8.2. Hospitals & Surgical Centers
12.8.3. Cryobanks & Research Institutes
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product
12.11.2. By Cycle
12.11.3. By Type
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific In Vitro Fertilization Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2020-2034
13.2.1. Equipment
13.2.2. Reagents & Media
13.2.3. Accessories
13.3. Market Attractiveness, by Product
13.4. Market Value Forecast, by Cycle, 2020-2034
13.4.1. Fresh Non-donor Cycle
13.4.2. Frozen Non-donor IVF Cycle
13.4.3. Frozen donor IVF Cycle
13.4.4. Fresh donor IVF Cycle
13.5. Market Attractiveness, by Cycle
13.6. Market Value Forecast, by Type, 2020-2034
13.6.1. Conventional IVF
13.6.2. IVF with ICSI
13.6.3. IVF with Donor Eggs
13.7. Market Attractiveness, by Type
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Fertility Clinics
13.8.2. Hospitals & Surgical Centers
13.8.3. Cryobanks & Research Institutes
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product
13.11.2. By Cycle
13.11.3. By Type
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America In Vitro Fertilization Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2020-2034
14.2.1. Equipment
14.2.2. Reagents & Media
14.2.3. Accessories
14.3. Market Attractiveness, by Product
14.4. Market Value Forecast, by Cycle, 2020-2034
14.4.1. Fresh Non-donor Cycle
14.4.2. Frozen Non-donor IVF Cycle
14.4.3. Frozen donor IVF Cycle
14.4.4. Fresh donor IVF Cycle
14.5. Market Attractiveness, by Cycle
14.6. Market Value Forecast, by Type, 2020-2034
14.6.1. Conventional IVF
14.6.2. IVF with ICSI
14.6.3. IVF with Donor Eggs
14.7. Market Attractiveness, by Type
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Fertility Clinics
14.8.2. Hospitals & Surgical Centers
14.8.3. Cryobanks & Research Institutes
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product
14.11.2. By Cycle
14.11.3. By Type
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa In Vitro Fertilization Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2020-2034
15.2.1. Equipment
15.2.2. Reagents & Media
15.2.3. Accessories
15.3. Market Attractiveness, by Product
15.4. Market Value Forecast, by Cycle, 2020-2034
15.4.1. Fresh Non-donor Cycle
15.4.2. Frozen Non-donor IVF Cycle
15.4.3. Frozen donor IVF Cycle
15.4.4. Fresh donor IVF Cycle
15.5. Market Attractiveness, by Cycle
15.6. Market Value Forecast, by Type, 2020-2034
15.6.1. Conventional IVF
15.6.2. IVF with ICSI
15.6.3. IVF with Donor Eggs
15.7. Market Attractiveness, by Type
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Fertility Clinics
15.8.2. Hospitals & Surgical Centers
15.8.3. Cryobanks & Research Institutes
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product
15.11.2. By Cycle
15.11.3. By Type
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Vitrolife AB
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Cook Medical
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Thermo Fisher Scientific, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Merck KGAA
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Ovascience, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. CooperSurgical
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Genea Ltd.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Rocket Medical PLC
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Fertility Focus Ltd.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
List of Tables
Table 01: Global In Vitro Fertilization Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 02: Global In Vitro Fertilization Market Size (US$ Mn) Forecast, by Cycle, 2020-2034
Table 03: Global In Vitro Fertilization Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 04: Global In Vitro Fertilization Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 05: Global In Vitro Fertilization Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 06: North America In Vitro Fertilization Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 07: North America In Vitro Fertilization Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 08: North America In Vitro Fertilization Market Size (US$ Mn) Forecast, by Cycle, 2020-2034
Table 09: North America In Vitro Fertilization Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 10: North America In Vitro Fertilization Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 11: Europe In Vitro Fertilization Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 12: Europe In Vitro Fertilization Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 13: Europe In Vitro Fertilization Market Size (US$ Mn) Forecast, by Cycle, 2020-2034
Table 14: Europe In Vitro Fertilization Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 15: Europe In Vitro Fertilization Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 16: Asia Pacific In Vitro Fertilization Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 17: Asia Pacific In Vitro Fertilization Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 18: Asia Pacific In Vitro Fertilization Market Size (US$ Mn) Forecast, by Cycle, 2020-2034
Table 19: Asia Pacific In Vitro Fertilization Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 20: Asia Pacific In Vitro Fertilization Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 21: Latin America In Vitro Fertilization Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Latin America In Vitro Fertilization Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 23: Latin America In Vitro Fertilization Market Size (US$ Mn) Forecast, by Cycle, 2020-2034
Table 24: Latin America In Vitro Fertilization Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 25: Latin America In Vitro Fertilization Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 26: Middle East & Africa In Vitro Fertilization Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 27: Middle East & Africa In Vitro Fertilization Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 28: Middle East & Africa In Vitro Fertilization Market Size (US$ Mn) Forecast, by Cycle, 2020-2034
Table 29: Middle East & Africa In Vitro Fertilization Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 30: Middle East & Africa In Vitro Fertilization Market Size (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global In Vitro Fertilization Market Size (US$ Mn), by Region, 2023 and 2034
Figure 02: Global In Vitro Fertilization Market Revenue (US$ Mn), by Product, 2023
Figure 03: Global In Vitro Fertilization Market Value Share, by Product, 2023
Figure 04: Global In Vitro Fertilization Market Revenue (US$ Mn), by Cycle, 2023
Figure 05: Global In Vitro Fertilization Market Value Share, by Cycle, 2023
Figure 06: Global In Vitro Fertilization Market Revenue (US$ Mn), by Type, 2023
Figure 07: Global In Vitro Fertilization Market Value Share, by Type, 2023
Figure 08: Global In Vitro Fertilization Market Revenue (US$ Mn), by End-user, 2023
Figure 09: Global In Vitro Fertilization Market Value Share, by End-user, 2023
Figure 10: Global In Vitro Fertilization Market Value Share, by Region, 2023
Figure 11: Global In Vitro Fertilization Market Value (US$ Mn) Forecast, 2020-2034
Figure 12: Global In Vitro Fertilization Market Value Share Analysis, by Product, 2023 and 2034
Figure 13: Global In Vitro Fertilization Market Attractiveness Analysis, by Product, 2024-2034
Figure 14: Global In Vitro Fertilization Market Value Share Analysis, by Cycle, 2023 and 2034
Figure 15: Global In Vitro Fertilization Market Attractiveness Analysis, by Cycle, 2024-2034
Figure 16: Global In Vitro Fertilization Market Value Share Analysis, by Type, 2023 and 2034
Figure 17: Global In Vitro Fertilization Market Attractiveness Analysis, by Type, 2024-2034
Figure 18: Global In Vitro Fertilization Market Revenue (US$ Mn), by End-user, 2023
Figure 19: Global In Vitro Fertilization Market Value Share, by End-user, 2023
Figure 20: Global In Vitro Fertilization Market Value Share Analysis, by Region, 2023 and 2034
Figure 21: Global In Vitro Fertilization Market Attractiveness Analysis, by Region, 2024-2034
Figure 22: North America In Vitro Fertilization Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 23: North America In Vitro Fertilization Market Attractiveness Analysis, by Country, 2024-2034
Figure 24: North America In Vitro Fertilization Market Value Share Analysis, by Country, 2023 and 2034
Figure 25: North America In Vitro Fertilization Market Value Share Analysis, by Product, 2023 and 2034
Figure 26: North America In Vitro Fertilization Market Value Share Analysis, by Cycle, 2023 and 2034
Figure 27: North America In Vitro Fertilization Market Value Share Analysis, by Type, 2023 and 2034
Figure 28: North America In Vitro Fertilization Market Value Share Analysis, by End-user, 2023 and 2034
Figure 29: North America In Vitro Fertilization Market Attractiveness Analysis, by Product, 2024-2034
Figure 30: North America In Vitro Fertilization Market Attractiveness Analysis, by Cycle, 2024-2034
Figure 31: North America In Vitro Fertilization Market Attractiveness Analysis, by Type, 2024-2034
Figure 32: North America In Vitro Fertilization Market Attractiveness Analysis, by End-user, 2024-2034
Figure 33: Europe In Vitro Fertilization Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 34: Europe In Vitro Fertilization Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 35: Europe In Vitro Fertilization Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 36: Europe In Vitro Fertilization Market Value Share Analysis, by Product, 2023 and 2034
Figure 37: Europe In Vitro Fertilization Market Value Share Analysis, by Cycle, 2023 and 2034
Figure 38: Europe In Vitro Fertilization Market Value Share Analysis, by Type, 2023 and 2034
Figure 39: Europe In Vitro Fertilization Market Value Share Analysis, by End-user, 2023 and 2034
Figure 40: Europe In Vitro Fertilization Market Attractiveness Analysis, by Product, 2024-2034
Figure 41: Europe In Vitro Fertilization Market Attractiveness Analysis, by Cycle, 2024-2034
Figure 42: Europe In Vitro Fertilization Market Attractiveness Analysis, by Type, 2024-2034
Figure 43: Europe In Vitro Fertilization Market Attractiveness Analysis, by End-user, 2024-2034
Figure 44: Asia Pacific In Vitro Fertilization Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 45: Asia Pacific In Vitro Fertilization Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 46: Asia Pacific In Vitro Fertilization Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 47: Asia Pacific In Vitro Fertilization Market Value Share Analysis, by Product, 2023 and 2034
Figure 48: Asia Pacific In Vitro Fertilization Market Value Share Analysis, by Cycle, 2023 and 2034
Figure 49: Asia Pacific In Vitro Fertilization Market Value Share Analysis, by Type, 2023 and 2034
Figure 50: Asia Pacific In Vitro Fertilization Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Asia Pacific In Vitro Fertilization Market Attractiveness Analysis, by Product, 2024-2034
Figure 52: Asia Pacific In Vitro Fertilization Market Attractiveness Analysis, by Cycle, 2024-2034
Figure 53: Asia Pacific In Vitro Fertilization Market Attractiveness Analysis, by Type, 2024-2034
Figure 54: Asia Pacific In Vitro Fertilization Market Attractiveness Analysis, by End-user, 2023-2034
Figure 55: Latin America In Vitro Fertilization Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 56: Latin America In Vitro Fertilization Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 57: Latin America In Vitro Fertilization Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 58: Latin America In Vitro Fertilization Market Value Share Analysis, by Product, 2023 and 2034
Figure 59: Latin America In Vitro Fertilization Market Value Share Analysis, by Cycle, 2023 and 2034
Figure 60: Latin America In Vitro Fertilization Market Value Share Analysis, by Type, 2023 and 2034
Figure 61: Latin America In Vitro Fertilization Market Value Share Analysis, by End-user, 2023 and 2034
Figure 62: Latin America In Vitro Fertilization Market Attractiveness Analysis, by Product, 2024-2034
Figure 63: Latin America In Vitro Fertilization Market Attractiveness Analysis, by Cycle, 2024-2034
Figure 64: Latin America In Vitro Fertilization Market Attractiveness Analysis, by Type, 2024-2034
Figure 65: Latin America In Vitro Fertilization Market Attractiveness Analysis, by End-user, 2024-2034
Figure 66: Middle East & Africa In Vitro Fertilization Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 67: Middle East & Africa In Vitro Fertilization Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 68: Middle East & Africa In Vitro Fertilization Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 69: Middle East & Africa In Vitro Fertilization Market Value Share Analysis, by Product, 2023 and 2034
Figure 70: Middle East & Africa In Vitro Fertilization Market Value Share Analysis, by Cycle, 2023 and 2034
Figure 71: Middle East & Africa In Vitro Fertilization Market Value Share Analysis, by Type, 2023 and 2034
Figure 72: Middle East & Africa In Vitro Fertilization Market Value Share Analysis, by End-user, 2023 and 2034
Figure 73: Middle East & Africa In Vitro Fertilization Market Attractiveness Analysis, by Product, 2024-2034
Figure 74: Middle East & Africa In Vitro Fertilization Market Attractiveness Analysis, by Cycle, 2024-2034
Figure 75: Middle East & Africa In Vitro Fertilization Market Attractiveness Analysis, by Type, 2024-2034
Figure 76: Middle East & Africa In Vitro Fertilization Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
In Vitro Fertilization Market
*86 figures and 60 tables includes